China Target Of 45 Percent Sales Growth This Year For Boehringer
This article was originally published in PharmAsia News
Executive Summary
China is expected to yield a 45 percent growth in sales for German drug maker Boehringer Ingelheim this year, particularly in the nation's rural areas